Last updated on February 2018

Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism


Brief description of study

The purpose of this study is to investigate if selenium supplementation to the standard treatment with anti-thyroid drugs in patients with Graves' hyperthyroidism, will lead to a fewer people with anti-thyroid treatment failure and faster remission, in terms of better quality of life during the first year of treatment and more patients staying in remission.

Clinical Study Identifier: NCT01611896

Find a site near you

Start Over